Multiple Sclerosis — Western vs Eastern Complementary Care

Western / Conventional Medicine Perspective

In conventional medicine, MS is understood as an immune-mediated, inflammatory, and neurodegenerative disease characterized by focal lesions and diffuse injury within the central nervous system. Diagnosis typically relies on the McDonald criteria, which integrate clinical history, neurologic examination, MRI findings, and in some cases cerebrospinal fluid markers such as oligoclonal bands. Conventional classification includes relapsing-remitting MS, secondary progressive MS, and primary progressive MS, although modern management increasingly recognizes that inflammatory activity and progression may overlap. Current research also highlights the importance of early disease control, since silent lesion formation and gradual neuroaxonal loss can occur even outside obvious relapses.

The cornerstone of standard treatment is the use of disease-modifying therapies (DMTs), which aim to reduce relapse frequency, MRI activity, and long-term disability accumulation. Additional conventional care often includes corticosteroids for acute relapses, rehabilitation therapies, mobility support, and medications or behavioral strategies for symptoms such as spasticity, neuropathic pain, depression, bladder dysfunction, and fatigue. Evidence supports exercise and physical therapy as important components of comprehensive care, with studies indicating benefits for strength, mobility, fatigue, mood, and quality of life when appropriately adapted. Mental health care and cognitive support are also increasingly recognized as central, not secondary, aspects of MS management.

From a complementary-care standpoint, western integrative medicine evaluates nonpharmacologic and natural approaches according to safety, mechanism, and clinical evidence. There is moderate evidence for some supportive practices such as exercise, mindfulness-based stress reduction, yoga, and selected rehabilitation modalities for improving quality-of-life outcomes in some patients. Evidence for supplements, special diets, cannabis-based products, acupuncture, and various manual or energy therapies is more mixed and often limited by small studies, heterogeneity, or inconsistent methods. Conventional clinicians therefore tend to frame these interventions as potential adjuncts for symptom management, while cautioning that they have not been shown to replace DMTs in controlling disease activity.

Safety remains a major concern in western care. People with MS may be vulnerable to drug-herb interactions, misleading claims, infection risk from unregulated products, or delays in evidence-based neurologic treatment. Heat sensitivity, fall risk, swallowing difficulties, and fluctuating neurologic impairment may also affect suitability for certain practices. For these reasons, conventional sources generally encourage coordinated, transparent communication among neurologists, primary care clinicians, rehabilitation specialists, and complementary practitioners.